In the dMMR cases, RECQL5 had the highest percent carrier count and all of the cases with predicted damaging RECQL5 variants had loss of MLH1; however, the same variants were present in several FCCTX and young onset cases with normal tumor expression of MLH1. Here, RECQL5 is linked to neoplasm.